Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Enhancing Solubility and Bioefficacy of Stilbenes by Liposomal Encapsulation-The Case of Macasiamenene F

V. Brezani, N. Blondeau, J. Kotouček, E. Klásková, K. Šmejkal, J. Hošek, E. Mašková, P. Kulich, V. Prachyawarakorn, C. Heurteaux, J. Mašek

. 2024 ; 9 (8) : 9027-9039. [pub] 20240215

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24005720

Stilbenes in food and medicinal plants have been described as potent antiphlogistic and antioxidant compounds, and therefore, they present an interesting potential for the development of dietary supplements. Among them, macasiamenene F (MF) has recently been shown to be an effective anti-inflammatory and cytoprotective agent that dampens peripheral and CNS inflammation in vitro. Nevertheless, this promising molecule, like other stilbenes and a large percentage of drugs under development, faces poor water solubility, which results in trickier in vivo administration and low bioavailability. With the aim of improving MF solubility and developing a form optimized for in vivo administration, eight types of conventional liposomal nanocarriers and one type of PEGylated liposomes were formulated and characterized. In order to select the appropriate form of MF encapsulation, the safety of MF liposomal formulations was evaluated on THP-1 and THP-1-XBlue-MD2-CD14 monocytes, BV-2 microglia, and primary cortical neurons in culture. Furthermore, the cellular uptake of liposomes and the effect of encapsulation on MF anti-inflammatory effectiveness were evaluated on THP-1-XBlue-MD2-CD14 monocytes and BV-2 microglia. MF (5 mol %) encapsulated in PEGylated liposomes with an average size of 160 nm and polydispersity index of 0.122 was stable, safe, and the most promising form of MF encapsulation keeping its cytoprotective and anti-inflammatory properties.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24005720
003      
CZ-PrNML
005      
20240412131020.0
007      
ta
008      
240405s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acsomega.3c07380 $2 doi
035    __
$a (PubMed)38434860
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brezani, Veronika $u Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, CZ-612 00 Brno, Czech Republic $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic $u IPMC, UMR 7275, Université Côte d'Azur, CNRS, 660 Route des Lucioles, Sophia Antipolis, F-06560 Valbonne, France $1 https://orcid.org/0000000329806334
245    10
$a Enhancing Solubility and Bioefficacy of Stilbenes by Liposomal Encapsulation-The Case of Macasiamenene F / $c V. Brezani, N. Blondeau, J. Kotouček, E. Klásková, K. Šmejkal, J. Hošek, E. Mašková, P. Kulich, V. Prachyawarakorn, C. Heurteaux, J. Mašek
520    9_
$a Stilbenes in food and medicinal plants have been described as potent antiphlogistic and antioxidant compounds, and therefore, they present an interesting potential for the development of dietary supplements. Among them, macasiamenene F (MF) has recently been shown to be an effective anti-inflammatory and cytoprotective agent that dampens peripheral and CNS inflammation in vitro. Nevertheless, this promising molecule, like other stilbenes and a large percentage of drugs under development, faces poor water solubility, which results in trickier in vivo administration and low bioavailability. With the aim of improving MF solubility and developing a form optimized for in vivo administration, eight types of conventional liposomal nanocarriers and one type of PEGylated liposomes were formulated and characterized. In order to select the appropriate form of MF encapsulation, the safety of MF liposomal formulations was evaluated on THP-1 and THP-1-XBlue-MD2-CD14 monocytes, BV-2 microglia, and primary cortical neurons in culture. Furthermore, the cellular uptake of liposomes and the effect of encapsulation on MF anti-inflammatory effectiveness were evaluated on THP-1-XBlue-MD2-CD14 monocytes and BV-2 microglia. MF (5 mol %) encapsulated in PEGylated liposomes with an average size of 160 nm and polydispersity index of 0.122 was stable, safe, and the most promising form of MF encapsulation keeping its cytoprotective and anti-inflammatory properties.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Blondeau, Nicolas $u IPMC, UMR 7275, Université Côte d'Azur, CNRS, 660 Route des Lucioles, Sophia Antipolis, F-06560 Valbonne, France
700    1_
$a Kotouček, Jan $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic
700    1_
$a Klásková, Eva $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic $1 https://orcid.org/0000000269841268
700    1_
$a Šmejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, CZ-612 00 Brno, Czech Republic
700    1_
$a Hošek, Jan $u Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, CZ-612 00 Brno, Czech Republic $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic
700    1_
$a Mašková, Eliška $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic
700    1_
$a Kulich, Pavel $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic
700    1_
$a Prachyawarakorn, Vilailak $u Chulabhorn Research Institute, Kamphaeng Phet 6 Road, Laksi, TH-10210 Bangkok, Thailand
700    1_
$a Heurteaux, Catherine $u IPMC, UMR 7275, Université Côte d'Azur, CNRS, 660 Route des Lucioles, Sophia Antipolis, F-06560 Valbonne, France
700    1_
$a Mašek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic
773    0_
$w MED00207589 $t ACS omega $x 2470-1343 $g Roč. 9, č. 8 (2024), s. 9027-9039
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38434860 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240412131013 $b ABA008
999    __
$a ok $b bmc $g 2076003 $s 1215482
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 9 $c 8 $d 9027-9039 $e 20240215 $i 2470-1343 $m ACS omega $n ACS Omega $x MED00207589
LZP    __
$a Pubmed-20240405

Najít záznam

Citační ukazatele

Možnosti archivace